Replies to post #226057 on Biotech Values

[biotech_researcher]

RVNC- “It could be big pharma is waiting on the labeling upon approval. Without that label, Daxi is another Botox wannabe,”

Bingo. Many here have become huge bulls on RVNC, including me, but this is without a doubt in my mind still a high risk investment.. Also, not just the risk in the label, but who ultimately markets it..